-
The new standards are available on the IGA website
-
In the first of a new video series, OT visited three practices near Leeds to find out how glaucoma pathways work
-
Nicotinamide, a form of B3, will be administered to study participants through Cardiff University research
-
The number of patients with age-related macular degeneration and glaucoma is set to grow in line with an ageing population. OT speaks with Hemal Mehta and Sally Ameen for insight on the latest treatment approaches
-
The Moorfields glaucoma service director discusses a non-invasive glaucoma treatment that could reduce the need for eye drops
-
The molecule protrudin could be used to help heal and regrow damaged nerve cells in the eye, resulting from conditions such as glaucoma
-
The company explained that MicroOptx’s technology will complement its own ophthalmic surgery equipment
-
The IGA also visited Specsavers’ head office to discuss how to improve detection, treatment and care
-
Area director of Northern Europe at Glaukos, Niven Smith (pictured), discusses the need to increase awareness of glaucoma treatment options